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GESTATIONAL FORM OF SUPPLEMENTAL SELENIUM (SE) AFFECTS 
STEROIDOGENIC GENE EXPRESSION IN THE NEWBORN CALF TESTIS 
Selenium (Se) is an important trace mineral in the diet of cattle. Our objective was 
to determine whether the form of supplemental Se fed to the dam would affect the 
expression of genes regulating steroidogenesis in the newborn testis. Twenty-four Angus-
cross cows were assigned randomly (n=8) to individual ad libitum access of a mineral 
mix containing 35 ppm of Se supplied as sodium selenite (inorganic, ISe; Prince Se), Sel-
Plex (organic, OSe; Sel-Plex, Alltech) or a 50/50 mix of ISe/OSe (MIX) 4 months prior 
to breeding and throughout gestation. All male calves were castrated within 2 days of 
birth and total testis RNA was subjected to microarray analysis using the Affymetrix 
Bovine 1.0 ST array.  Ingenuity Pathway Analysis of differentially expressed genes, 
separated by one-way ANOVA (p<0.05) and a post-hoc LSD test, identified eight 
mRNAs associated with steroidogenesis. Specifically, mRNAs involved in the 
conversion of testosterone to estradiol were increased in the testis of OSe-supplemented 
when compared to ISe-supplemented animals, and mRNAs encoding genes regulating the 
conversion of androstenedione to testosterone or androstenedione to estradiol were 
decreased in the testis of MIX-supplemented when compared to ISe-supplemented cows. 
Expression in the neonate may equate to differences in fertility in the adult animal.  
KEYWORDS: cattle, mRNA, selenium, steroidogenesis, testis 
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CHAPTER ONE 
Review of the Literature 
INTRODUCTION 
 
 Selenium is an important trace mineral in the diet of many livestock species, 
including cattle. It plays a role in the immune system, as an antioxidant, and has several 
effects on reproductive function [1].  Low concentrations of selenium (Se) in the soil in 
many parts of the U.S. necessitate supplementation to cattle diets [2]. Deficient animals 
suffer negative effects including reduced growth rates [3], reduced neutrophil numbers 
[4], and an increased incidence of white muscle disease and calf pneumonia [3]. The most 
relevant effects to this review are those that concern reproductive efficiency [5-6]. The 
differing forms of Se have been shown affect livestock in various ways. Organic 
selenium (OSe) is more efficient at being transferred to the calf, in utero and in 
colostrum, when compared to the inorganic (ISe) forms [7].  In ruminants, as in 
monogastrics, urinary excretion is greater when ISe was supplemented and tissue 
absorption was decreased [2].  
Selenium supplementation in the male may affect testis structure, testosterone 
production, or sperm characteristics. In male rats, a Se-deficiency was reported to 
decrease testis mass and biosynthesis of testosterone [8]. The addition of Se to gossypol-
treated ram diets reversed the negative effects and serum testosterone and sperm motility 
was increased [9]. The same effect was observed when Se supplementation was provided 
to cadmium-exposed rats [10-11].  
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Changes in the female reproductive system have also been observed with 
differing Se treatments. The ovary is a very sensitive organ and Se has been observed to 
affect estradiol production in several species. In mice, sodium selenite (ISe) improved the 
growth of preantral follicles in vitro [12] and the production of estradiol in granulosa 
cells of cows was also increased with an inorganic form [13].  Se-deficient female rats are 
also reported to experience ovarian degeneration and follicular atresia [14].  
The following review will focus on steroidogenesis and the effect Se may have on 
this process.  The steroidogenic capacity of the animal plays a pivotal role in reproductive 
efficiency and, therefore, profitability. Effects have been shown in the male and female of 
various species, and steroidogenic pathway in the gonads points toward a pertinence of 
Se in both genders. Given the effect of a Se deficiency on steroidogenesis by the testis [8-
9, 15] and ovary [13-14], the requirement to supplement Se in many parts of the US [2] 
and evidence that the form of Se supplemented affects the response within a tissue [16], 
our objective was to determine whether the form supplemental Se (inorganic, organic, or 
a 50/50 mix) fed to the dam during gestation would affect the expression of genes 
regulating steroidogenesis in the testis of the newborn bull calf.   
 
SELENIUM 
Overview 
 
 Selenium (Se), a trace mineral necessary for livestock, acts as an antioxidant and 
has many negative impacts if excluded from the diet or provided in insufficient amounts 
[3-6].  In areas with Se-deficient soil, and therefore Se-deficient forages, farmers must 
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supplement their livestock with this trace mineral. Negative effects may include an 
increased incidence of white muscle disease and calf pneumonia [17], as well as reduced 
rates of growth [3], reduced neutrophil numbers [4] and fertility [5-6].  Selenium 
deficiencies may also inhibit IgG response, the efficiency of the mitochondrial transport 
chain [7], and increase the risk of immunodeficiency, myopathy, and cardiovascular 
disease [18].  
Due to low concentrations of Se in many parts of the country, especially in the 
southeastern United States, supplementation of Se directly to the diet of cattle is 
necessary [2].  Dietary concentrations of less than 0.5 ppm are considered Se deficient 
[19], and when supplementation is necessary, the form in which Se is supplemented to 
diets can affect tissue concentrations and levels of assimilation [20].  The standard 
industry supplementation regimen is an inorganic form, however organic Se is more 
closely related to the Se found naturally in plants and may therefore be more biologically 
active; supplementation with organic Se (Se yeast) is reported to increase whole blood 
levels of Se when compared to supplementation with inorganic forms [7]. 
 The Role of Selenium 
 
Selenium is necessary for the formation of glutathione peroxidases (GSHPx), 
antioxidants that can help prevent cell damage, stimulate the immune system and aid in 
the removal of cellular waste [21].  Glutathione peroxidases catalyzes the breakdown of 
hydrogen peroxide and lipid hydroperoxides; they are involved in both extracellular and 
intracellular protection of the membranes [22]. Selenium has been shown to be involved 
in the protection of cells against the toxicity of ROS (reactive oxygen species) [12].  It is 
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classified as a “free radical scavenger” and can be useful in protecting the cell [13].  
These reactive oxygen species may overwhelm the cells and contribute to reproductive 
issues. Antioxidants are often used to negate these issues; selenium, particularly in its 
involvement with glutathione peroxidase, may help minimize the problems associated 
with ROS.   
Selenium, an important component of selenoproteins, is necessary to provide 
proper oxidant-antioxidant balance. The increase of IL-2 receptor expression in 
lymphocytes is influenced by Se presence; these interactions lead to an increased number 
of lymphocytes, increased cytotoxicity of killer cells, and increased antibody production 
by B cells [12]. It is this influence of Se that allows it to help counteract the toxicity of 
ROS in the body, helping to prevent oxidative stress and associated reproductive issues.   
  Inorganic selenium supplements are used exclusively in the synthesis of 
selenocysteine in the mammalian body; organic selenium may be incorporated into any 
protein that contains methionine [23]. Mammalian selenoproteins (such as glutathione 
peroxidase or thioredoxin reductase) catalyze the reduction of hydrogen peroxide (H2O2; 
a reactive oxygen species) and the reduction of thioredoxin at the expense of NADPH 
[24].  
In rats, increase in Se levels increased the expression and activation of 
selenoprotein P and glutathione peroxidase [25]. Levels of ROS may influence 
inflammatory gene expression leading to the assumption that selenium has the capability 
to affect inflammatory responses by regulating these ROS, and the oxidative stress of 
cells [26]. It has also been reported that a moderate Se deficiency may alter the Nrf2 and 
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Wnt pathways [27]. Expression of selenoprotein activity differs with physiological status 
and age of the animal [28] and may also be dependent on the cycling status of the female 
[29].  
Types of Selenium 
 
 The two forms of selenium often provided to livestock are organic supplements, 
such as selenomethionine or selenocysteine, or inorganic supplements, such as sodium 
selenite or sodium selenate. The current supplementation regime in industry is to feed an 
inorganic form; this inorganic supplement is cheaper than other forms. Recent research 
shows that there may be some advantages to feeding the organic selenium, which is more 
closely related to the Se form in natural plants and may therefore be more biologically 
active. One study showed that the supplementation with Se yeast (organic selenium) 
increased the whole blood levels when compared to inorganic forms, in a span of only 
two weeks. There was a significant difference in the blood levels of Se between the 
organic and inorganic groups but there was no difference when the glutathione 
peroxidase activity was examined [30].  
Metabolism of Selenium 
 
 Selenium is metabolized in the body differently depending on the form supplied 
(organic vs inorganic) and the animal itself (ruminant vs monogastric). In monogastric 
animals, a difference between selenite and selenomethionine metabolism has been 
reported [31-33]. In ruminants, the inorganic supplement selenite (ISe) is reduced to 
insoluble compounds more readily than the organic supplement selenomethionine 
(SeMet; OSe), this reduction could influence absorption [34].  In sheep, significantly 
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greater absorption has been observed with SeMet when compared to selenite [34].  One 
study reported that rumen microbes reduce inorganic selenium to inabsorbable inorganic 
selenide, resulting in availability of only 25-30% [35].  
 In the inorganic forms, selenate is converted to selenite, which is reduced to 
selenide. The selenide may then be methylated, incorporated into the oxidase system of 
cellular membranes, or may bind to Se-binding proteins. As a last step in inorganic Se 
metabolism, selenide may be incorporated as a substrate for the selenophosphate 
synthetase, which mediates the synthesis of selenoproteins [36].  
In the organic forms of supplementation, however, the dietary selenomethionine is 
incorporated into proteins [36]. It is then metabolized into Se-adenosyl methionine and 
through a series of steps, to selenocysteine. The selenocysteine may then be incorporated 
into proteins or degraded, which would release the selenite, or it can be degraded by 
selenocysteine lyase; both degradation processes result in selenide being available for the 
body to use and it is then metabolized as stated above [36]. 
 Inorganic Se forms are often released and may re-combine within the digestive 
system to make the insoluble complexes, reducing the absorption in the small intestine. 
The organic forms appear to be more actively absorbed by peptide and/or amino acid 
mechanisms [36-37]. Absorption of Se may also be altered by differences in gender, age, 
physiological status or health of the animals [36, 38-39].  
Selenium in Kentucky 
 
 The selenium content of forages is related to the nutrients from the soil in which 
they are grown. It has been shown that the forages grown in the southeast part of this 
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country, including Kentucky, have very low levels of selenium (less than 0.1 ppm) [2]. 
There is also evidence that of all cattle operations surveyed, beef operations have the 
highest number of selenium deficient animals (≤0.08 μg/mL Se in whole blood) [2]. The 
dietary requirement of beef cattle is about 0.1 ppm of the dry matter intake (or 0.10 
mg/kg diet); therefore, it is clear that supplementation is necessary to meet the minimum 
requirements, particularly in this part of the country.  
 
STEROIDOGENESIS 
Overview 
 
 Steroidogenesis is the process by which steroid hormones are synthesized. These 
hormones are responsible for development and function of the bovine reproductive tract. 
In the female gonad, steroidogenesis occurs in both the granulosa cells and theca interna 
of the ovarian follicle. In the male gonad, steroidogenesis occurs in the leydig cells of the 
testis. Although many enzymes and hormones are involved in steroidogenesis, this 
review will describe only the most recognized components. Both genders will also be 
addressed in this review, as the effects of Se on steroidogenesis are not restricted to the 
male.  
Follicle Stimulating Hormone 
 
 In the male, follicle stimulating hormone (FSH) is not directly involved in 
steroidogenesis; it stimulates the Sertoli cells to produce androgen binding protein and 
initiates spermatogenesis [40]. However, the utilization of this pituitary gonadotropin is a 
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key signal in ovarian steroidogenesis.  A transient increase in FSH stimulates the ovary to 
recruit a cohort of developing antral follicles. The receptors for this hormone are 
localized to the granulosa cells in the female and are responsible for the production of 
androgens [41] . Follicle stimulating hormone has been shown to increase the expression 
of several other enzymes involved in steroidogenesis including aromatase, P450scc, and 
StAR in granulosa cells [42].   
Luteinizing Hormone 
 
 Luteinizing hormone (LH) has a stimulatory effect on the production of 
testosterone by the Leydig cells in the testis of the male which influences the secondary 
sex characteristics [40]. It binds to receptors on leydig cells and stimulates the synthesis 
and secretion of testosterone [40]. The total production of androgens is stimulated by LH- 
activation of StAR expression [43]. In the female, LH is essential for the continued 
growth and maturation of the follicle [41, 44]. The receptors for LH are located primarily 
in the theca cells, and the expression of several hormones (i.e. StAR and CYP17) 
depends on stimulation by LH [45-46].  The negative feedback loop of LH and FSH 
promotes growth of the dominant follicle; it has been shown that the FSH and estradiol 
interaction may stimulate the induction of LH receptors in granulosa cells [47].  
Steroidogenic acute regulatory protein 
 
 Steroidogenic acute regulatory protein (StAR), is integral to fertility as the rate 
limiting step of steroidogenesis. It is expressed in the theca cells of the female and the 
leydig cells of the male. StAR regulates the transportation of cholesterol into the inner 
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mitochondrial membrane [43]. In one study examining aging leydig cells of rats, a 
decrease in testosterone production was observed in “old” rats. Concentrations of StAR 
were decreased in these cells, but LH stimulation in vitro restored StAR  to the normal 
abundance in all testis ages [48]. When theca cells and granulosa cells were separated by 
a collagen membrane in a cell culture setup, FSH increased the production of StAR in 
vitro [42]. This culture resulted in the increase of StAR in granulosa cells; the expression 
of this protein is dependent on the stage of follicular development [42].  
Cytochrome P450 side chain cleavage 
 
 After StAR transports cholesterol into the inner mitochondrial membrane, 
P450scc (cytochrome P450 side chain cleavage) converts it into pregenelone (or other 
progestins) [49]. The leydig cells of the testis express P450scc and the mRNA levels for 
this enzyme decrease as the animal ages [48]. Expression of P450scc in granulosa cells is 
associated with the recruitment of follicles during the early part of folliculogenesis [41].  
Theca cells and/or granulosa cells may express P450scc, depending on the stage of 
follicular development [50-51]. In a collagen separation culture, FSH increased the 
mRNA expression of P450scc in granulosa cells, corresponding to an increase in 
progesterone production [42].  
3β-hydroxysteroid dehydrogenase and 17α- hydroxylase  
 
Pregnenelone is either converted to progesterone by 3β-hydroxysteroid 
dehydrogenase (3β-HSD) through the A4-pathway [50-51] or to dehydroepiandrosterone 
(DHEA) by 17α-OH through the A5 pathway [50, 52]. In the fetal male rat, expression of 
these enzymes begins before the typical start of steroidogenesis , approximately day 15.5 
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post-coitum [53]. Expression of 3β-HSD is related to the selection of the dominant 
follicle in the female [49]. 17α-OH, or Cyp17, may be stimulated by LH in the theca cells 
which increases the production of androgens [43]. The synthesis of estradiol is dependent 
on the expression of 17α-OH in the theca interna and the production of androstenedione 
and aromatase in the granulosa cells [54].  
P450 aromatase   
 
 P450aromatase (P450arom or Cyp19) is responsible for the conversion of 
testosterone to estradiol. Expression of P450arom has been observed in the Sertoli and 
leydig cells of the testis; in addition to expression in several germ cell variations 
(pachytene spermatids, round spermatids, elongated spermatids, and the flagella of late 
spermatids) [55]. In the male mammal, aromatase inhibitors have been shown to inhibit 
and/or block male sexual behavior [56] and aromatase knockout mice exhibited impaired 
spermatogenesis [55]. In the female, the expression of P450aromatase mRNA is 
associated with the recruitment of follicles [17]. Theca cells, when cultured on the 
opposite side of a collagen membrane from granulosa cells, increased the expression of 
P450arom in granulosa cells [42]. This resulted in an increase in estradiol production 
because Cyp19, often referred to as aromatase, catalyzes the last part of estrogen 
synthesis and granulosa cells of dominant follicles are responsible for the majority of its 
production [42] [57].  
17β-hydroxysteroid dehydrogenase  
 
 17β-hydroxysteroid dehydrogenase (17β-HSD) is involved in the conversion of 
androstenedione to testosterone or estrone to estradiol [58]. There are various isoforms of 
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this enzyme, each seems to play a particular role in the activation, or inactivation, of 
androgens and estrogens [59].  
Alternate Pathways 
 
 The process described above is the classic steroidogenic pathway; however, there 
are alternate pathways that may be used in certain situations. In fetal gonadal 
development and differentiation, dihydroxytestosterone (DHT) is an important hormone 
for the development of secondary sex characteristics, and is produced from testosterone 
[60]. In some cases in marsupials, rodents, and humans there is also an alternate, or 
“backdoor” pathway to synthesize DHT without a testosterone intermediate [60]. The two 
pathways involved in testosterone biosynthesis appear to be the Δ5- or the Δ4-pathway; 
the former seems to be most common in the testis of rodents and the latter in the primate 
testis [61]. Reports also provide evidence for the involvement of peroxidase and 
superoxide dismutase, stimulated by LH, in testosterone production [61]. Research 
suggest a role for these in luteal steroidogenesis and in the pubertal synthesis of 
testosterone in mice [61]. Other enzymes, in the non-classical steroidogenic pathway, 
may help control levels of testosterone and estradiol in males and females.  
 
SPERMATOGENESIS 
Overview 
 
 A brief description of spermatogenesis is included in this review, strictly to 
highlight normal male gonadal function and fertility. Spermatogenesis occurs in the testis 
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of the male, specifically in the Sertoli cells of the seminiferous tubules. This process is 
regulated by testosterone levels in the male, levels that are controlled completely by the 
action of enzymes and genes involved in steroidogenesis. 
Step 1: Spermatocytogenesis 
 
 The first step of spermatogenesis is spermatocytogenesis and involves the 
proliferation of the germ cells via mitosis. In the basement membrane of the seminiferous 
tubules, the spermatogonia undergo several mitotic divisions. These divisions allow for 
the maintenance of a proliferative germ cell population (each A1 makes another A1 and 
an A2) and the rate of new spermatogonia production occurs much faster than the actual 
maturation of the spermatozoa. The mitotic divisions in the seminiferous tubules are 
regulated by FSH and help to establish Sertoli cell function. At the completion of 
spermatocytogenesis, the cells are called primary spermatocytes [62].  
Step 2: Meiosis 
 
 When the male reaches puberty, the primary spermatocytes undergo meiosis. This 
occurs in the ad luminal space of the seminiferous tubules and provides the production of 
a haploid gamete. This process allows for the increase of genetic variability due to 
independent assortment and crossing over that may occur during meiosis. After the first 
meiotic division, the primary spermatocytes are referred to as secondary spermatocytes; 
once they undergo a second meiotic division, they become spermatids. After Sertoli cell 
function has fully developed, testosterone produced by the leydig cells (and stimulated by 
LH production) maintains spermatogenesis [62].  
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Step 3: Spermiogenesis 
 
 Spermiogenesis is the last stage of sperm cell differentiation and also occurs in 
the ad luminal space of the seminiferous tubules. In this process, the spermatids mature 
into spermatozoa. Several changes to the germ cells occur at this step: the nucleus 
condenses and histones in the DNA are replaced by protamines, excess cytoplasm is 
removed from the sperm, and the acrosome and tail form. After spermiogenesis, the 
spermatozoa are mature and may be released from the testis in a process called 
spermiation [62].  
Summary 
 
 Spermatogenesis is an important process for the reproductive capacity in the male. 
Changes or problems in any of the steps may alter the efficiency and fertility of the 
animal. 
 
ROLE OF ESTRADIOL IN THE MALE 
 
 Although estradiol has traditionally been termed the “female” hormone and 
testosterone the “male” hormone, current research points to the importance of estradiol 
(and other estrogens) in the normal health and fertility of males. In humans and other 
mammals, the impact of estradiol has been studied with a role for this hormone in brain 
development and proper sperm function reported. Estrogen receptors (ER) are present in 
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many tissues of both males and females; in the male this expression is high in the efferent 
ductules of the testis and in the epididymis [63].  
In estrogen receptor knockout male mice, abnormal sperm morphology and 
significantly reduced sperm concentrations were observed [63]. These mice were infertile 
but no abnormalities observed in the testis until the onset of puberty; at this point, the 
testis became atrophic [63]. The efferent ductules play an important role in the 
transportation of sperm from the testis to the epididymis, and the estrogen receptors affect 
the absorptive capacity of this system [63]. In ERα knockout mice, the testosterone 
production of the leydig cells was 2-fold higher when compared to their wild type 
counterparts [64]. In these animals, the testis also expressed higher steroidogenic 
enzymatic activity, particularly in StAR, P450 (17alpha) and 17-βHSD III expression 
[64].  
Brain differences and sex-specific behaviors have been studied in several species 
but most predominantly in mice. Male mice lacking aromatase, which converts 
androstenedione to estradiol, did not exhibit the typical sex-specific behaviors of 
aggression and territorial behaviors seen in wild type animals [65]. Although mice make 
very little testosterone at birth (the levels increase significantly with the onset of puberty), 
there is relocation of some of the testosterone secreted after birth to the brain; if 
aromatase is present, the testosterone may be converted to estrogen aiding  in the male-
specific development of the neural circuits [65]. Sexual behavior, such as mounting, was 
only abnormal when both ER receptors (α and β) were knocked-out in one study, but 
aggressive behavior was diminished significantly when only one receptor was disrupted 
[66].  
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EFFECT OF SELENIUM 
In vivo studies 
 
 To study the impact of selenium (Se) and deficiency on the male, several in vivo 
studies have been performed. Selenium deficiency in rats was examined to determine the 
effect on testicular morphology and testosterone production [8]. Four generations of 
Wistar rats were fed one of two diets: low Se or Se-adequate (sodium selenite, ISe). Rats 
were fed the treatments for 150 days; the group of rats fed the low Se diet exhibited a 
slight decrease in serum testosterone levels. Injection of GnRH or LH (as hCG) resulted 
in a marked decrease in the testosterone production of Se-deficient animals when 
compared to those in the control group. After the second generation of Se-deficient rats, 
the testicular mass decreased and there was a significant increase in seminiferous tubule 
atrophy [8].  
Gossypol is a toxic pigment found in cottonseed meal, a common feed for 
ruminants. It has been shown to reduce serum testosterone, presumably by inducing 
regression of leydig cells [9]. A study was performed in mature crossbred rams to 
determine the impact of Se supplementation (as sodium selenite, 1 mg Se/day) on the 
negative effects of gossypol toxicity, which may include decreased antioxidant 
concentrations and abnormal sperm morphology [9]. The rams were given a control diet 
(no free gossypol/no Se supplementation), a low gossypol/Se supplementation or a high 
gossypol/Se supplementation to examine the function and ability of selenium to 
counteract the toxic reproductive effects of gossypol in mature rams [9]. Libido, semen, 
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blood and hormones were analyzed for the 8 week period (determined by the duration of 
spermatogenesis in rams). Regardless of gossypol level supplied, serum concentrations of 
testosterone were reduced when compared to control animals. Supplementation with Se 
resulted in an increase in testosterone levels in both diet groups; increased libido, sperm 
motility, and ejaculate volume were also observed when rams were supplemented with Se 
[9].   
Cadmium is an environmental pollutant that has become more commonly linked 
to illnesses around the world [11]. In the leydig cells, cadmium (Cd) has been shown to 
decrease and disrupt steroidogenesis [11]. In rats, research shows that rats exposed to Cd 
(as CdCl2) had significantly lower serum testosterone levels than control animals. This 
decline was reversed with the administration of Se, as sodium selenite (ISe injection). In 
addition, testicular levels of 3β-HSD and 17β-HSD were restored to more normal levels 
in Cd exposed rats when treated with Se [11].  
These studies show the impact of Se in the live animal, particularly when applied 
to male testosterone production. Supplementation with this trace mineral may counteract 
negative reproductive effects of gossypol or cadmium. 
In vitro Studies  
 
Various species, both male and female, have shown effects of Se on reproductive 
traits or efficiency. Steroidogenesis in both genders has been shown to impact the fertility 
of the animals. In the female, silent heats, lowered conception rates and overall decreased 
fertility have been shown. Due to the likely effects of Se in the female, the process of 
folliculogenesis and the estrous cycle have been reviewed (Appendix 1).  
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In humans, low levels of Se have been suggested to be a contributing factor in 
spontaneous abortions [67]. Other studies have actually shown the opposite effect, where 
those mothers with increased serum Se experienced recurrent abortions [68]. Low Se 
levels have also been shown to be related to preterm birth in women. There is clearly a 
fine line between the benefits and repercussions of selenium levels (deficiency vs 
toxicity) and further investigation is required to determine its impact on pregnancy and 
parturition.   
Several studies have been performed in vitro to examine the significance of 
selenium (Se) in follicle maturation and proliferation. One such study showed that the 
addition of selenium to a serum-free media increased estradiol production and granulosa 
cell differentiation [69]. Media termed ITS, or a mixture of 5 mg/ml insulin, 5mg/ml 
transferring and 5 g/ml of selenium, was added to mouse primary granulosa cells and 
cultured for 2 days. After the 2-day culture period the cells were P450arom positive and 
there was an increase in several steroidogenic mRNA transcripts [69]. The presence of 
P450arom exhibited the aromatase activity of the granulosa cells, offering the suggestion 
that the cells were “still pure” granulosa cells and contained the potential to produce 
estradiol [69]. The other treatments did not have the same increase in steroidogenic 
transcripts or in estradiol production, implying that the addition of selenium to the 
medium aided in the granulosa cell differentiation and maturation [69].  
 Researchers have also identified the importance of selenium in granulosa cell 
steroidogenesis and proliferation [13]. Bovine granulosa cells obtained from varying 
follicle sizes were examined to establish the role of selenium and its interaction with 
bFSH (bovine follicle stimulating hormone) [13]. The researchers found that selenium 
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increased the proliferation in cells obtained from small follicles and that estradiol 
production increased in granulosa cells from all size follicles; however, the presence of 
bFSH did not have an effect on the activity as selenium did not interact with the bFSH 
[13].  
Reactive oxygen species (ROS) production and the effect of sodium selenite (SS) 
on this production were examined in cultured mice ovaries. Free radicals are common in 
in vitro studies because the oxygen concentration is often much higher [12]. Reactive 
oxygen species are important for gamete formation, fertilization and cell growth but a 
significant level of ROS molecules can be detrimental to the cells by inducing oxidative 
stress and apoptosis [12]. It has been reported that the addition of SS improved the in 
vitro growth of mouse pre-antral follicles in a medium that contained fetal bovine serum 
[12]. In a separate study, several treatments of SS were added to a base medium. The 
follicles cultured without sodium selenite exhibited a large concentration of ROS [12]. 
Follicles cultured with selenium (at varying concentrations) had levels of ROS that were 
considered baseline [12]. The addition of SS also increased the antioxidant capacity of 
the cultured cells.  
 These studies show the importance of selenium in the in vitro culture of cells, 
implying that the same impact may be necessary for proper in vivo follicle formation and 
development. After review of the literature, it is the objective of this research to 
determine the impact of Se form during gestation on the steroidogenic gene expression 
profile in the newborn calf testis. No information has been found studying the effect of 
gestational selenium on calf testis and mRNA expression levels.   
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CHAPTER TWO 
 
Gestational form of supplemental selenium (Se) affects steroidogenic gene 
expression in the newborn calf testis 
 
STATEMENT OF THE PROBLEM 
 
Selenium (Se) is an important trace mineral in the diet of many livestock species, 
including cattle.  It often acts as an antioxidant stimulating the formation of glutathione 
peroxidase [1].  If present within the diet in insufficient quantities, animal production  
parameters can be negatively affected [12].  Negative effects may include an increased 
incidence of white muscle disease and calf pneumonia [3], as well as reduced rates of 
growth [3], reduced neutrophil numbers [4] and fertility [5-6].  
Due to low concentrations of Se in the soil and therefore forages in many parts of 
the country, especially in the southeast US, supplementation of Se directly to the diet of 
cattle is beneficial [2].  Dietary concentrations of less than 0.5 ppm are considered Se 
deficient [19], and when supplementation is necessary, the form in which Se is 
supplemented to diets can affect level of tissue assimilation.  Inorganic forms include 
sodium selenite and sodium selenate, organic forms are typically supplied as Se-enriched 
yeast, an indirect form of Se as selenomethionine (SeMet) or selenocysteine (SeCys) 
[70].  The standard industry supplementation regimen is of an inorganic form, however 
organic Se is more closely related to the Se found naturally in plants and may therefore 
be more biologically active. Supplementation with organic Se (Se yeast) is reported to 
increase whole blood levels of Se when compared to supplementation with inorganic 
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forms [16], and organic forms carry a lower level of risk for toxicity than inorganic forms 
[18].   
Although Se status is known to affect the reproductive health and fertility of cattle 
[6], the mechanisms involved are still being delineated, especially those related to source 
and steroidogenesis.  In male rats, a deficiency in Se is reported to decrease testis mass, 
biosynthesis of testosterone, and GnRH- and LH-induced production of testosterone [8].  
Supplementation of Se also increases serum concentrations of testosterone in gossypol-
treated rams and bulls [9, 15] and cadmium-exposed rats [10-11].  Effects of Se status on 
steroidogenesis by the ovary have also been documented.  In mice, sodium selenite 
improves the growth of preantral follicles in vitro [12] and in rats, a deficiency in Se can 
result in ovarian degeneration and follicular atresia [14].  In cattle, inorganic Se increases 
the production of estradiol by granulosa cells in vitro [13] and in pigs, supplementation 
with organic versus inorganic forms of selenium affects estradiol profiles, with the OSe 
animal having higher concentrations of estradiol [71].  With one role of Se being to 
counter negative effects attributed to the production of reactive oxygen species (ROS) 
[12], Se-dependent effects on steroid production by the testis and/or ovary may be due to 
effects of excess ROS on the transfer of cholesterol [8] that is requisite for steroid 
production by these endocrine organs.  
The differing forms of Se supplementation (organic vs inorganic) have been 
shown to affect livestock in various ways. OSe has been observed to be more efficient at 
being transferred to the calf (via placenta and milk) when compared to ISe forms [7]. At 
the end of the fattening period for feedlot cattle, higher concentrations of Se in blood 
plasma were seen in those supplemented with organic Se [18]. In addition to tissue 
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differences between the Se forms, gene expression may also be altered. Various forms of 
Se, including an organic, an inorganic and a mix of the two, were supplemented to the 
diet of growing beef cattle and hepatic genes were differentially expressed depending on 
Se supplementation and Se form of supplement [20].  
The objective of this research was to determine whether the form of supplemental 
Se (inorganic, organic, or a 50/50 mix) fed to the dam during gestation would affect the 
expression of genes regulating steroidogenesis in the testis of the newborn bull calf.  We 
hypothesized that maternal form of gestational Se will affect gene expression profiles 
within the newborn testis, effects that may impact steroidogenesis and fertility in the 
mature bull. The effects of Se on reproductive capacity in various species, and both 
genders, are known; in the bull, these changes may contribute to differing testosterone 
levels, alterations in libido, and semen characteristics.  
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MATERIALS AND METHODS 
Animal and Experimental Conditions 
 
 All animal work took place at the University of Kentucky Research and Education 
Center (UKREC) in Princeton, KY. Animal procedures were approved by the University 
of Kentucky Institutional Animal Care and Use Committee. Twenty-four Angus cross 
cows, managed under a forage-based cow-calf production regimen and bred to the same 
bull, were assigned randomly (n=8) to individual ad libitum access of a common mineral 
mix. The mix contained 35 ppm of Se supplied as sodium selenite (inorganic Se; Prince 
Se), Sel-Plex (organic Se; Sel-Plex, Alltech), or a 50/50 mix of ISe/OSe (Mix) for 4 
months prior to breeding and throughout gestation, for a total of approximately 13 
months. Cows were trained via grain incentive over a 3-week period to use in-pasture 
Calan gates (American Calan, Inc., Northwood, NH, USA) prior to the start of the study. 
Dams commonly grazed a predominantly tall fescue-mixed grass pasture or had common 
access to round bales of primarily tall fescue hay (when provided). Forages supplied were 
considered Se deficient with the pasture containing 0.06±0.04 mg Se/kg on average and 
the content of the hay was 0.11±0.03 mg Se/kg on average [72].  
Individual ad libitum access to Se treatment was maintained by Calan gates which 
were checked daily to provide a continual supply of the treatment mixes. Concentration 
of Se in the vitamin-mineral mixes provided to the cows, analyzed by Dairy One 
Cooperative, Inc. (Ithaca, NY, USA), was as follows: 33.3±4.40 mg/kg for ISe, 
35.14±4.82 mg/kg for OSe, and 33.5±4.58 mg/kg for MIX treatment [72]. Mineral 
consumption was measured by collecting orts every 28 days and the amount offered 
minus the orts reported as the amount of mineral-vitamin consumed. Mineral intake did 
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not differ with Se treatment provided [72]. Se intake was also measured, calculated as the 
product of total mineral consumption and the Se content of each of the treatments (OSe: 
35.1 Se mg/kg; ISe: 33.3 mg Se/kg; MIX: 33.5 mg Se/kg). The mean individual Se 
consumption was 1.35-3.74 mg/day for OSe animals, 0.63-3.16 mg/day for ISe animals, 
and 0.73-3.20 mg/day for MIX animals [72]. Whole blood was collected every 28 days 
via jugular venipuncture and analyzed for Se concentration (Donald C. Mahan, The Ohio 
State University, Columbus, OH, USA). Although the animals consumed less than 3 
mg/day, on average, the Se levels were still adequate or highly adequate in all treatment 
groups [72].  
Thirteen bull calves were born in the 2012 fall calving season (ISe n=5; OSe n=4; 
Mix n=4). Castration was performed using the general practice of open surgical 
castration, within 2 days of calf birth, and testis samples were stored in RNAlater, an 
RNA stabilizing reagent (Qiagen, Valencia, CA).  
RNA extraction 
 
Total RNA was extracted for each tissue sample using TRIzol reagent (Invitrogen, 
Carlsbad, CA) and purified through RNeasy columns (Qiagen, Valencia, CA), as 
described before and according to manufacturer’s directions [73]. RNA quality and 
quantity analysis (Eppendorf BioPhotomer Plus) showed 260/280 ratios greater than 1.6 
for every sample. RNA quality was verified using the Agilent 2100 Bioanalyzer System 
(Agilent Technologies, Santa Clara, CA), and an RNA integrity number (RIN) of 9.1-9.7 
determined for all samples.   
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Microarray Analysis 
 
Microarray hybridization was performed using the Affymetrix Bovine 1.0 ST 
arrays (Affymetrix; DNA Microarray Core Facility, University of Kentucky, Lexington, 
KY) per the manufacturer’s standard protocol. Two hundred-fifty ng of RNA was used 
for each array and manufacturer’s instructions followed for the Ambion WT Expression 
Kit protocol. Briefly, this kit generates sense-strand cDNA from total RNA and makes it 
possible to fragment and label the single strand cDNA for hybridization. To fragment and 
label the cDNA, the WT Expression Kit followed by the Affymetrix GeneChip WT 
Terminal Labeling Kit was used.  Five µg of fragmented and labeled DNA target was 
hybridized for each array; the hybridization took 16 hrs at 45° C in the GeneChip 
Hybridization Oven 640. Following hybridization, the arrays were washed, stained and 
then scanned on the Affymetrix 7G scanner. Data was collected by expression consul 
software and the resultant 38*.cel files were imported into Partek Genomic Suite 
Software (Partek, St. Louis, MO) for analysis.  The dataset was normalized using the 
Robust Multichip Averaging (RMA) algorithm and corrected for GC content.  
Statistical Analysis 
 
  A one-way ANOVA was used to identify Se treatment effects of mRNA 
abundance. Significantly different genes were designated by P<0.05 and LSMeans 
separated by a post-hoc LSD (least significant difference) test in Partek Genomic Suite 
Software (Partek, St. Louis, MO), to determine pair-wise comparisons and treatment 
effects.  This data set was uploaded, and using the bovine setting with direct and indirect 
relationships shown, pathways were identified using Ingenuity® Pathway Analysis 
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software (IPA® , QIAGEN, Redwood City, CA, www.qiagen.com/ingenuity) to 
determine the effect of treatment on the expression of mRNAs specifically regulating 
steroidogenesis.  
 Analysis of whole blood Se levels during calving month was performed using 
SigmaStat 3.5 (Systat Software, Inc., San Jose, CA) by a one-way ANOVA, followed by 
a post-hoc LSD test to separate treatment means.  
Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) Analysis 
 
To enable future analysis of gene expression, RT-PCR was performed to generate 
products that could then be sequenced to confirm correct product amplification.  First, 
total RNA was extracted from testis samples using TRIzol reagent (Invitrogen) and the 
RNeasy®Mini-Kit with an on-column DNA digestion (Qiagen Sciences, MD). The 
cDNA was then synthesized using the SuperScript III 1st Strand Synthesis System 
(Invitrogen), with 1 ug of RNA used for each reverse transcription reaction. Gene-
specific primer pairs that were developed using Primer-BLAST from NCBI and 
manufactured by Integrated DNA Technologies are shown in Table 2.1. The specificity 
of the primers was verified by running PCR products on a 1% agarose gel and by analysis 
of the melting curve for each reaction. PCR was performed using the iQ SYBR Green 
Supermix (Bio-RAD) on a Mastercyler®ep realplex2 (Eppendorf AG, Hamburg). This 
process was performed with a total volume of 25 ul: 5 ul of cDNA, 12.5 ul of SYBR 
Green, 5.5 ul of DEPC water, and 1 ul of each 10 uM primer stock  (forward and 
reverse). A temperature gradient was performed to determine the appropriate reaction 
temperature for each set of primers. The thermal cycling conditions for the gradient were: 
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95° C for 2 min; 40 cycles of 95° C for 30 sec, one of a dozen temperatures ranging from 
50° to 65° C for 30 sec, 72° C for 30 sec; 95° C for 15 sec; and a melting curve program 
using a gradual increase from 60° C to 95° C for 20 min (0.15°C/s).  
Once the melting curves were examined and appropriate reaction temperatures 
determined, RT-PCR samples were validated by sequence analysis. Briefly, the products 
were purified using the QIAquick® Gel Extraction Kit (Qiagen Sciences, MD) before 
being sent for Sanger sequencing by the University of Florida DNA Sequencing Core 
Laboratory (Gainesville, FL) using forward and reverse primers (Table 2.1).  
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RESULTS 
Animal Model 
 
In this study, forages supplied were considered Se deficient with the pasture 
containing 0.06±0.04 mg Se/kg on average and the content of the hay was 0.11±0.03 mg 
Se/kg on average. Whole blood Se levels were examined in both cow and calf blood 
samples. Samples were considered Se deficient if levels were less than 0.080 ug/mL, Se 
adequate if levels were between 0.081-0.16 ug/mL and Se highly adequate if levels were 
greater than 0.161 ug/mL. In the ISe treatment, animals were adequate (0.11-0.19 
ug/mL), with MIX animals considered adequate to highly adequate (0.15-0.20 ug/mL) 
and OSe cow levels at highly adequate levels (0.17-0.27 ug/mL) [72]. A physiological 
status difference was observed in the whole blood Se levels using a within-treatment 
polynomial trend analysis; a cubic effect of period was seen with the ISe (P<0.0001) and 
MIX (P=0.01) animals, and a quartic effect of period on OSe (P=0.003) cows (shown in 
Figure 2.1) [72].  
 Se concentrations during calving month in the cow showed no difference between 
ISe and MIX animals and a significant increase in the levels of OSe animals (p<0.05; 
Figure 2.2). When calf blood was examined during calving month, levels were similar 
among all treatments although tended to be higher in OSe animals (P=0.068; Figure 2.3).    
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Microarray Analysis 
 
Overall, 1112 genes were differentially expressed (DEG; p<0.05) by the 
treatment. After pathway analysis was performed, eight genes involved in steroidogenesis 
and steroid receptor binding were determined to be differentially expressed. Five unique 
patterns of gene expression were observed among the DEG (shown in Tables 2.2 and 
2.3). For aldo-keto reductase family 1, member C4 (Akr1c4), hydroxysteroid (17-β) 
dehydrogenase 4 (Hsd17b4), and toll-like receptor 3 (Tlr3) levels of mRNA for OSe and 
ISe treatments were similar, with levels of mRNA in the MIX treatment significantly 
lower (p<0.02). In contrast, while expression of estrogen sulfotransferase (Sult1e1) 
showed no differences between the OSe and ISe, levels of mRNA in the MIX treatment 
was significantly higher (p<0.05). Natriuretic peptide receptor A/guanylate cyclase A 
(Npr1) expression was greater in OSe (p<0.04) than in MIX or ISe treatments. Levels of 
mRNA for cytochrome P450, family 2, subfamily S, polypeptide 1 (Cyp2s1) and cyclin-
dependent kinase 5, receptor 1 (Cdk5r1) expression were greater in MIX cows (p<0.05) 
than OSe, no effect of treatment was observed in cows fed ISe. Expression profiles for 
Hsd17b7 varied significantly between all treatments (p<0.004) with the greatest 
expression seen in the OSe treatment than ISe cows; and in ISe than MIX animals (OSe > 
ISe > MIX).    
RT-PCR Analysis 
 
To facilitate future research, sequencing for each of the steroidogenic DEG was 
performed. Sequences are shown in Figure 2.4; successful alignments are provided for all 
genes except Npr1. 
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Table 2.1. Primers for differentially expressed genes affecting steroidogenesis and 
steroid receptor binding 
Gene Temp 
(°C) 
Primers bp 
HSD17B7  52.5 F: ACA GCT GAA GGA CTG CTG AC  
R: CCA GAC AGT GCT TCT GTT CCA 
 
452 
HSD17B4 60.2 F: TGG GGA AGA GGT GGT CAA GA 
R: AGT CTG CCA CTA AAG ACC GC 
 
404 
HSD17B4(b) 60.2 F: GTC TGA ACT CCA CTC GGC AC 
R: GAA CGG TCC CTC AGA ATC CC 
 
382 
AKR1C4 60.2 F: AGC AAT CGA TGG CCT CAA CA  
R: TCA ATG CTT TCA AGC CTT CAC T 
 
258 
SULT1E1 60.2 F: CCT GAG TGG GGA TTG AAG AA 
R: CAC AGG CAG GTG AGA CTT CA 
 
450 
SULT1E1(b) 60.2 F: TCT TTC CCG GAA TGC CAA GG 
R: AGC ACT TGC GGA TTC TTG CT 
 
186 
CYP2S1 60.2 F: TCA TCA GCA CCC AGA CAC AC 
R: CTG TGG ATG GCG ACA GTC TT 
 
373 
TLR3 54.3 F: CAA CTT GAG ACG CCT GGA CT 
R: GAC AAC CAG CGA GCG ATA GA 
 
221 
TLR3(b) 
 
 
CDK5R1 
60.2 
 
 
62 
F: ACC ATG AGC AGA CCT TTG CC 
R: ACA GTT CTG GCT CCA GCT TT 
 
F: CTC GGT GAG CGT CTT TCC T 
R: CCT TGG CGT TCT TGC TGT TC 
 
289 
 
 
261 
 
 
*F, Forward  
*R, Reverse 
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Figure 2.1. Whole blood Se concentrations of Angus-cross cows over a year-long, 
fall-calving, forage based production regimen 
 
 
Adapted from Patterson, J.D., et al., Individual intake of free-choice mineral mix by 
grazing beef cows may be less than typical formulation assumptions and form of selenium 
in mineral mix affects blood Se concentrations of cows and their suckling calves. Biol 
Trace Elem Res, 2013. 155(1): p. 38-48 
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Figure 2.2. Cow whole blood Se levels in calving month 
 
Blood Se from dams during the month of calving analyzed by one-way ANOVA and 
separated by a post-hoc LSD test is shown in the above graph. 1Bars with different 
superscripted letters differ (P<0.05). 
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Figure 2.3. Calf whole blood Se levels in calving month 
 
 
 
 
 
 
 
 
 
 
 
Whole blood analyzed for Se concentration from calves analyzed by one-way ANOVA 
and separated by a post-hoc LSD test are shown in the above graph.  There was a 
tendency for OSe whole blood Se concentrations to be higher than ISe or MIX (P=0.068) 
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Table 2.2. Effect of Se treatment on expression of genes encoding enzymes involved in steroidogenesis and steroid receptor 
binding 
 
Dietary Se Treatments1 
GenBank 
Sequence Gene Symbol OSe MIX ISe SEM2 P-Value3 Description 
NM_001083375.1 HSD17B7 9.03a 8.30b 8.67c 0.514 0.004 hydroxysteroid (17-β) dehydrogenase 7 
NM_001007809.1 HSD17B4 11.07a 10.82b 11.04a 0.134 0.022 hydroxysteroid (17-β) dehydrogenase 4 
NM_1810272.2 AKR1C4 6.43a 5.17b 6.37a 2.852 0.011 aldo-keto reductase family 1, member C4  
NM_177488.2 SULT1E1 4.38a 4.57b 4.37a 0.132 0.049 
sulfotransferase family 1E, estrogen-preferring, 
member 1 
NM_001100366.1 CYP2S1 6.67a 6.90b 6.75a,b 0.139 0.054 
cytochrome P450, family 2, subfamily S, 
polypeptide 1 
NM_001008664.1 TLR3 9.06a 8.46b 8.85a 0.586 0.017 Toll-like receptor 3 
NM_001192751.1 NPR1 7.84a 7.65b 7.64b 0.12 0.043 
Natriuretic peptide receptor A/guanylate 
cyclase A 
NM_174512.3 CDK5R1 6.24a 6.49b 6.33a,b 0.138 0.033 
Cyclin-dependent kinase 5, regulatory subunit 1  
(aka p35) 
         
 
1LSMeans with different superscripted letters 
differ (p<0.04)     
 2 The SEM values presented were 
pooled from the treatments            
  
3 P-value from model associated with one-way 
ANOVA       
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Table 2.3. The effect of Se treatment on the expression of mRNA encoding genes 
regulating steroidogenesis and steroid receptor binding  
 
  OSe vs MIX OSe vs ISe  MIX vs ISe 
Gene 
Fold 
Change P-value 
Fold 
Change P-Value 
Fold 
Change P-value 
HSD17B7 1.6555 0.00108 1.27801 0.04228 -1.29542 0.03395 
HSD17B4 1.18658 0.01288 1.101565 0.77849 -1.1683 0.01596 
AKR1C4 2.440093 0.00741 1.04583 0.86039 -2.29572 0.00741 
SULT1E1 -1.14557 0.03653 1.00368 0.94652 1.14979 0.02596 
CYP2S1 -1.1744 0.01946 -1.06189 0.29938 1.10595 0.09628 
TLR3 1.51153 0.005903 1.15582 0.227267 -1.30776 0.038371 
NPR1 1.14151 0.033181 1.1468 0.022578 1.00464 0.929341 
CDK5R1 -1.19302 0.011823 -1.06465 0.277285 1.12058 0.063346 
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Figure 2.4. Comparison of RT-PCR products to their respective GenBank sequences  
Underlined sequences indicate the position of the primers (forward and reverse) 
Vertical lines indicate identical base pairs between product and template sequences 
Query: NM_#### 
Sbjct: Gene (i.e. Hsd17b7) 
 
Gene Alignment 
 
Hsd17b7 against 
NM_001083375.1  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
301 tccacagcta aatatcaaag cacttttccg tggtctcttt tcaagaaaag tgattcatat 
361 gttctccaca gctgaaggac tgctgaccca gaatgacaag ataa 
 
Query  405  CCCCTGATGGGCTCCAGGAGGTGTTTGAAACCAATGTCTTTGGCCACTTTATCCTGATTC  464 
            |||||| |||||||||||| ||||||||||||||||||||||||| |||||||||||||| 
Sbjct  39   CCCCTG-TGGGCTCCAGGA-GTGTTTGAAACCAATGTCTTTGGCC-CTTTATCCTGATTC  95 
 
Query  465  AGGAACTAGAATCTCTCCTGTGTCACAGTGAGAGTCCATCTCAGCTCATTTGGACATCAT  524 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  96   AGGAACTAGAATCTCTCCTGTGTCACAGTGAGAGTCCATCTCAGCTCATTTGGACATCAT  155 
 
Query  525  CTCGCAATGCAAAGAAATCTAATTTCAGCTTTGAGGATGTCCAGCACAGCAAAGGCCAGG  584 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  156  CTCGCAATGCAAAGAAATCTAATTTCAGCTTTGAGGATGTCCAGCACAGCAAAGGCCAGG  215 
 
Query  585  AGCCCTACAGCTCTTCCAAATACGCGATTGACCTTCTGAGTGTGGCTTTGAACAGACACT  644 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  216  AGCCCTACAGCTCTTCCAAATACGCGATTGACCTTCTGAGTGTGGCTTTGAACAGACACT  275 
 
Query  645  TCAACCATCAGGGTCTGTATTCCAGTGTAGTGTGCCCAGGTACGATGCTGACCAATTTGA  704 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  276  TCAACCATCAGGGTCTGTATTCCAGTGTAGTGTGCCCAGGTACGATGCTGACCAATTTGA  335 
 
Query  705  CATATGGAATTCTACCTCCCTTTGTGTGGATGTTAATCATGCCAATCATATGGCTGTTAC  764 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  336  CATATGGAATTCTACCTCCCTTTGTGTGGATGTTAATCATGCCAATCATATGGCTGTTAC  395 
 
Query  765  GCTTTTTTGCAAACGCTTTCACGTTGACACCTCACAATGGAACAGAAGCACTGGTCTGG  823 
            ||||||||||||||||||||||||||||||||||||||||||||||||||||| ||||| 
Sbjct  396  GCTTTTTTGCAAACGCTTTCACGTTGACACCTCACAATGGAACAGAAGCACTG-TCTGG  453 
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Figure 2.4. (continued) 
Gene Alignment 
 
 
Hsd17b4 against 
NM_001007809.1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1981 gtttgaagaa ataggtcgcc gccttcaggg tattggggaa gaggtggtca agaaagtccg 
2041 tgctgtgttt 
Query  2051  GAGTGGCATATCACTAAAGGTGAAAATACTGCAGCCAAGTGGACTATTGACCTGAAAACT  2110            
|            |||| ||||||||||||||||| ||||||||||||||||||||||||||||||||||||| 
Sbjct 13     GAGT-GCATATCACTAAAGGTG-AAATACTGCAGCCAAGTGGACTATTGACCTGAAAACT  70 
 
Query  2111  GGTTCTGGAAAAGTGTATCAAGGCCCTGCAAAAGGCTCTGCTGATGTAACCATCACACTT  2170 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  71    GGTTCTGGAAAAGTGTATCAAGGCCCTGCAAAAGGCTCTGCTGATGTAACCATCACACTT  130 
 
Query  2171  TCAGATGAAGATTTCATGGAAGTAGTCTTGGGCAAGCTTGATCCTCAGAAGGCGGTCTTT  2230 
             ||||||||||||||||||||||||||||||||||||||||||||| |||||||||||||| 
Sbjct  131   TCAGATGAAGATTTCATGGAAGTAGTCTTGGGCAAGCTTGATCCTAAGAAGGCGGTCTTT  190 
 
Query  2231  AGTGGCAGACT  2241 
             ||||||||||| 
Sbjct  191   AGTGGCAGACT  201 
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Figure 2.4. (continued) 
Gene Alignment 
 
Hsd17b4(b) against 
NM_001007809.1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1 cctgaacccg ccactccctc cgttttagct gcctcggagt ctgaactcca ctcggcacta 
61 cttctgctgg tgtgtgtgt 
Query  80   gtgCCGCTGCAGACTAGACTTATGGCCTCGACGTTGAGGTTCAACGGGAGGGTGGTACTG  139 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1    GTGCCGCTGCAGACTAGACTTATGGCCTCGACGTTGAGGTTCAACGGGAGGGTGGTACTG  60 
 
Query  140  GTTACCGGCGCGGGGGGAGGATTGGGCCGAGCCTATGCCCTGGCTTTTGCAGAAAGAGGT  199 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  61   GTTACCGGCGCGGGGGGAGGATTGGGCCGAGCCTATGCCCTGGCTTTTGCAGAAAGAGGT  120 
 
Query  200  GCATCAGTTGTTGTGAATGACCTAAGAGGGGACTTCACAGGAGTTGGCAAAGGCTCCTTA  259 
            |||||||||||||||||||||||| ||||||||||||||||||||||||||||||||||| 
Sbjct  121  GCATCAGTTGTTGTGAATGACCTAGGAGGGGACTTCACAGGAGTTGGCAAAGGCTCCTTA  180  
 
Query  260  TCTGCTGATAAGGTTGTTGAAGAAATAAGAAGGAAAGGTGGAAAAGCAGTGGCTAACTAT  319 
             ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  181  GCTGCTGATAAGGTTGTTGAAGAAATAAGAAGGAAAGGTGGAAAAGCAGTGGCTAACTAT  240 
 
Query  320  GATTCAGTGGAGGAAGGGGAGAAGATTGTGAAGACAGCACTGGATGCTTTTGGAAGAATA  379 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  241  GATTCAGTGGAGGAAGGGGAGAAGATTGTGAAGACAGCACTGGATGCTTTTGGAAGAATA  300 
 
Query  380  GATATTGTGATCAACAATGCTGGGATTCTGAGGGACCGTTCA  421 
            |||||||||||||||||||||||||||||||||||||||||| 
Sbjct  301  GATATTGTGATCAACAATGCTGGGATTCTGAGGGACCGTTCA  342 
 
 
 
 
 
Figure 2.4. (continued) 
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Gene                           
 
Akrc14 against 
NM_181027.2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Alignment 
 
 
Query  887   AGCAATCGATGGCCTCAACAGCAATATGAGATATAATGAGCTATTACTGGGTGTTGGTCA  946 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  211   AGCAATCGATGGCCTCAACAGCAATATGAGATATAATGAGCTATTACTGGGTGTTGGTCA  152 
 
Query  924   GAGCTATTACTGGGTGTTGGTCACCCTGAGTATCCATTTGTTGAAGAATATTGACTGTGA  983 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  213   GAGCTATTACTGGGTGTTGGTCACCCTGAGTATCCATTTGTTGAAGAATATTGACTGTGA  272 
 
Query  984   GCTGTACACGTGCATTCTACCAGAACATCTTGCTTCTAGGGCTGTGAAGAGGATTTCTGT  1043 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  273   GCTGTACACGTGCATTCTACCAGAACATCTTGCTTCTAGGGCTGTGAAGAGGATTTCTGT  332 
 
Query  1044  ACTTGGTAGACGTGCTTaaaaaaaCTGTCTTCCACTTCAAAAACTTGCCTTTCCTTTATT  1103 
             |||||||||| ||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  333   ACTTGGTAGAGGTGCTTAAAAAAACTGTCTTCCACTTCAAAAACTTGCCTTTCCTTTATT  392 
 
Query  1104  AAAAAATATTTTATGAAATAGTGAAGGCTTGAAAGCATTGA  1144 
             ||||||||||||||||||||||||||||||||||||||||| 
Sbjct  393   AAAAAATATTTTATGAAATAGTGAAGGCTTGAAAGCATTGA  433 
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Figure 2.4. 
(continued) 
 
Gene 
 
 
Sult1e1 against 
NM_177488.2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Alignment 
 
 
Query  133  CCTGAGTGGGGATTGAAGAAAACTGAATTGGATTAC  168 
            |||||||||||||||||||||||||||||||||||| 
Sbjct  36   CCTGAGTGGGGATTGAAGAAAACTGAATTGGATTAC  1 
 
Query  169  CCAGTTGCTTTCACAGGATCATCTGGACAGTGTACCACTCCACGATGAGTTCTTCCAAAC  228 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  37   CCAGTTGCTTTCACAGGATCATCTGGACAGTGTACCACTCCACGATGAGTTCTTCCAAAC  96 
 
Query  229  CATCCTTTTCAGATTACTTTGGCAAACTTGGTGGAATACCAATGTATAAAAAATTTATCG  288 
            |||||||||| ||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  97   CATCCTTTTC-GATTACTTTGGCAAACTTGGTGGAATACCAATGTATAAAAAATTTATCG  155 
 
Query  289  AGCAGTTTCATAACGTGGAGGAATTTGAGGCAAGACCAGATGACCTTGTCATTGTCACCT  348 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  156  AGCAGTTTCATAACGTGGAGGAATTTGAGGCAAGACCAGATGACCTTGTCATTGTCACCT  215 
 
Query  349  ATCCCAAATCTGGTACAACATGGCTTAGTGAAATTATATGCATGATTTATAATAACGGTG  408 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  216  ATCCCAAATCTGGTACAACATGGCTTAGTGAAATTATATGCATGATTTATAATAACGGTG  275 
 
Query  409  ATGTGGAAAAGTGCAAAGAAGACGTCATTTTTAATAGAGTTCCTTACCTGGAATGTAGCA  468 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  276  ATGTGGAAAAGTGCAAAGAAGACGTCATTTTTAATAGAGTTCCTTACCTGGAATGTAGCA  335 
 
Query  469  CTGAACACGTGATGAAAGGAGTGAAACAATTAAATGAGATGGCATCTCCTAGAATAGTGA  528 
            |||||||||||||||| ||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  336  CTGAACACGTGATGAATGGAGTGAAACAATTAAATGAGATGGCATCTCCTAGAATAGTGA  395 
 
Query  529  AGTCTCACCTGCCTGTGA  546 
            |||||||||||||||||| 
Sbjct  396  AGTCTCACCTGCCTGTGA  413 
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Figure 2.4. (continued) 
Gene Alignment 
 
 
Sult1e1(b) against 
NM_177488.2 
 
 
 
 
 
 
 
 
 
 
 
 
Query  591  TATCTTTCCCGGAATGCCAAGGATGTGGTTGTTTCTTATTATTTTTTAATTTTAATGGTG  650 
            ||||||||||||||||||||||||||||||||||||||||||||||| |||||||||||| 
Sbjct  152  TATCTTTCCCGGAATGCCAAGGATGTGGTTGTTTCTTATTATTTTTTCATTTTAATGGTG  93 
 
Query  651  ACTGCTATTCCAGATCCTGACTCTTTTCAAGATTTTGTG   
            ||||||||||||||||||||||||||||||||||||||| 
Sbjct  92   ACTGCTATTCCAGATCCTGACTCTTTTCAAGATTTTGTG     
 
Query  690  GAGAAATTCATGGATGGAGAAGTTCCTTATGGTTCCTGGTTTGAACATACAAAATCTTGG  749 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  210  GAGAAATTCATGGATGGAGAAGTTCCTTATGGTTCCTGGTTTGAACATACAAAATCTTGG  269 
 
Query  750  TGGGAAAAGAGCAAGAATCCGCAAGTGCTA  779 
            |||||||||||||||||||||||||||||| 
Sbjct  270  TGGGAAAAGAGCAAGAATCCGCAAGTGCTA  299 
 
 
  
Cyp2s1 against 
NM_001100366.1 
 
 
 
 
 
 
 
 
Query  1881  GTCATCAGCACCCAGACACACCCACAAGAACCATAAGGCAA  1921 
             ||||||||||||||||||||||||||||||||||||||||| 
Sbjct  41    GTCATCAGCACCCAGACACACCCACAAGAACCATAAGGCAA   
Query  1921  ACTGCACCACACTGCTTTCTAAAGACAGAAATTCAGCCCATCTGAAATCACGACCACATA  1980 
             ||||| || ||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  40    ACTGC-CC-CACTGCTTTCTAAAGACAGAAATTCAGCCCATCTGAAATCACGACCACATA  97 
 
Query  1981  CCCAGGTAACCCACCGACTCAACACACAGCACAACCACCCTGGACTCAGCCCACACGTGG  2040 
             ||||| |||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  98    CCCAGATAACCCACCGACTCAACACACAGCACAACCACCCTGGACTCAGCCCACACGTGG  157 
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Figure 2.4. (continued) 
Gene Alignment 
 Query  2041  GCATTCAGCTGCTGCCTTTACAACTCACGGAAATGGCCACAGTGTTTGTGGCCCTCATGC  2100 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  158   GCATTCAGCTGCTGCCTTTACAACTCACGGAAATGGCCACAGTGTTTGTGGCCCTCATGC  217 
 
Query  2101  CCTCTGAGCACATCAAATTTACCGGTGCCACCGTCTCTGGGAGCCTGGAGCAGAGACCCC  2160 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  218   CCTCTGAGCACATCAAATTTACCGGTGCCACCGTCTCTGGGAGCCTGGAGCAGAGACCCC  277 
 
Query  2161  AGGCTGGGTCATATCACCACACACATGTTCTCAGAGAGGTATGTCCCTTGGTGACCCTAC  2220 
             |||||||||||||||||||||||||||| ||||||||||||||||||||||||||||||| 
Sbjct  278   AGGCTGGGTCATATCACCACACACATGTCCTCAGAGAGGTATGTCCCTTGGTGACCCTAC  337 
 
Query  2221  CGCTATCTAGGCATAAGACTGTCGCCATCCACAG  2254 
             |||||||||||||||||||||||||||||||||| 
Sbjct  338   CGCTATCTAGGCATAAGACTGTCGCCATCCACAG  371 
 
 
Tlr3 against 
NM_001008664.1 
 
 
 
 
 
 
 
 
 
 
 
1081 tccaacttga gacgcctgga cttgagacgg tcttttacta gac 
Query  1124  AAAGCATTTCACTGACTTCGCTCCCCAAGATTGACGATTTTTCCTTTCAGTGGCTAAAAT  1183 
             ||||| |||| ||||||||||||||||||||||||||||||||||||| ||||||||||| 
Sbjct  1     AAAGC-TTTC-CTGACTTCGCTCCCCAAGATTGACGATTTTTCCTTTC-GTGGCTAAAAT  57 
 
Query  1184  GTTTGGAGTACCTCAACATGGACGATAACAACTTTCCAGGCATAAAAAGAAATACTTTCA  1243 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  58    GTTTGGAGTACCTCAACATGGACGATAACAACTTTCCAGGCATAAAAAGAAATACTTTCA  117 
 
Query  1244  CGGGATTGGTGAGGCTGAAATTTTTAAGTCTCTCCAACTCCTTCTCAAGTTTGCGGACTT  1303 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  118   CGGGATTGGTGAGGCTGAAATTTTTAAGTCTCTCCAACTCCTTCTCAAGTTTGCGGACTT  177 
 
Query  1304  TAACAAATGAGACATTTCTATCGCTCGCTGGTTGTC  1339 
             |||||||||||||||||||||||||||||||||||| 
Sbjct  178   TAACAAATGAGACATTTCTATCGCTCGCTGGTTGTC  213 
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Figure 2.4. (continued) 
 
 
Gene  Alignment 
Tlr3(b) against 
NM_001008664.1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Query  112  ACCATGAGCAGACCTTTGCCTTATCATATCCACTTCTTTTCGGGACTGTTGACCTGTTGG  171 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1    ACCATGAGCAGACCTTTGCCTTATCATATCCACTTCTTTTCGGGACTGTTGACCTGTTGG  60 
 
Query  172  ATACTGTGTACATCTTCTGCCCACAAATGTACTGTTAGACATGAAGTAGCTGATTGCAGT  231 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  61   ATACTGTGTACATCTTCTGCCCACAAATGTACTGTTAGACATGAAGTAGCTGATTGCAGT  120 
 
Query  232  CATCTGAAGTTGACGCAAATACCTGATGACCTCCCAACAAACATAACTGTGTTGAATCTC  291 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  121  CATCTGAAGTTGACGCAAATACCTGATGACCTCCCAACAAACATAACTGTGTTGAATCTC  180 
 
Query  292  ACCCATAATCAACTCAGAAGATTGCCACCTGCCAATTTTACGAGATACAGCCAACTTACT  351 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  181  ACCCATAATCAACTCAGAAGATTGCCACCTGCCAATTTTACGAGATACAGCCAACTTACT  240 
 
Query  352  ACCTTGGATGGGGGATTTAACTCCATCTCAAAGCTGGAGCCAGAACTGT  400 
            | ||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  241  ATCTTGGATGGGGGATTTAACTCCATCTCAAAGCTGGAGCCAGAACTGT  289 
 
Cdk5r1 against 
NM_174512.3 
 
 
 
61 gaggggcggc acgcgacctc gggagcgccc ccgcctcccc ctggcctccg cggctcggtg 
121 agcgtctttc ctccagccgg caggctggcc gcaggggcgc gggtccc 
Query  168  CGCCCGGCGCGCAGCGGCACCATGGGCACGGTGCTGTCCCTGTCCCCCAGCTACCGGAAG  227 
            |||||||||||||||||| ||||||||||||||||||||||||||||||||||||||||| 
Sbjct  21   CGCCCGGCGCGCAGCGGC-CCATGGGCACGGTGCTGTCCCTGTCCCCCAGCTACCGGAAG  79 
 
Query  228  GCCACGCTGTTTGAGGATGGCGCGGCCACGGTGGGCCACTACACGGCCGTGCAGAACAGC  287 
            | |||||||||||||||||| ||||||||||||||||||||||||||||||||||||||| 
Sbjct  80   GACACGCTGTTTGAGGATGGTGCGGCCACGGTGGGCCACTACACGGCCGTGCAGAACAGC  139 
 
Query  288  AAGAACGCCAAGGACAAGAACCT  310 
            |||||||||||||| |||| ||| 
Sbjct  140  AAGAACGCCAAGGA-AAGACCCT  161 
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DISCUSSION AND CONCLUSION 
 
 Selenium has been shown to have positive effects on reproduction and growth when 
added to the diet of various livestock species. Due to the low soil levels of Se in the southeastern 
U.S., including Kentucky, supplementation is necessary. Supplementation with inorganic versus 
organic Se affects tissue accumulation, gene expression and whole blood Se levels [2, 20, 74]. In 
this experiment, the addition of one of three Se forms (organic, inorganic, or a 50/50 mix) to the 
diet of cattle affected the transcriptome in the testis of the newborn bull calf.   
When dams were supplemented with organic, inorganic, or 50/50 mix of organic and 
inorganic Se throughout gestation, analysis of the testis of their newborn bull calves revealed 
treatment effects on the expression of several mRNAs involved in steroidogenesis.  Specifically, 
mRNAs involved in the conversion of testosterone to estradiol were increased in the testis of 
OSe-supplemented when compared to ISe-supplemented animals, and mRNAs encoding genes 
regulating the conversion of androstenedione to testosterone or androstenedione to estradiol were 
decreased in the testis of MIX-supplemented when compared to ISe-supplemented cows. 
Steroidogenesis within the testis is essential for male fertility; the process occurring 
within the leydig cells of the testis.  Key substrates and proteins required for the production of 
testosterone by the testis include cholesterol, the precursor for all of the steroid hormones; 
steroidogenic acute regulatory protein (StAR) which regulates the transport of cholesterol into 
the inner mitochondrial membrane; and luteinizing hormone (LH) which stimulates the total 
production of androgens by activating the expression of StAR [43].  Enzymes including 
cytochrome P450 side chain cleavage (P450scc) which is involved in the conversion of 
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cholesterol to a progestin, primarily pregnenolone; 3β-hydroxysteroid dehydrogenase (3β-HSD), 
which is involved in the conversion of pregnenolone to progesterone in the smooth endoplasmic 
reticulum [75]; cytochrome P450 17-hydroxylase/17 20-lyase (Cyp17), which is involved in 
the conversion of progesterone to androstenedione [58]; and 17-hydroxysteroid dehydrogenase 
(17-HSD), which is involved in the conversion of androstenedione to testosterone [58], are all 
well documented.  However, the biosynthetic pathway responsible for determining the total 
concentration of circulating testosterone can also be affected by a range of other enzymes 
involved in either the generation and/or catabolism of the bioactive end product.  Our results 
indicate that the source of supplemental Se fed to dams during gestation effects the expression of 
mRNAs involved in these less well-defined mediators of steroidogenesis, effects that may 
translate to changes in the total steroidogenenic capacity of the testis (Figures 2.5 and 2.6).  
Importantly to the interpretation of our results, modern microarray technologies utilize 
multiple probes that span the entire length of the known nucleotide sequence.  The recently 
developed bovine 1.0 ST arrays offer higher probe coverage, measuring expression across the 
entire gene, resulting in increased resolution and greater accuracy when compared to the classical 
3’-based arrays.   
Notably, supplementation of dams throughout gestation with ISe, OSe, or a 50/50 MIX of 
inorganic plus organic Se affected the expression of mRNA encoding Hsd17b7 and Akr1c4 in the 
newborn calf testis.  For both these mRNAs, expression within the testis of calves born from 
MIX-supplemented dams was lower than in the testis of calves born from OSe- and ISe-
supplemented dams.  Levels of mRNA for Hsd17b7, but not Akr1c4, were also higher in the 
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testis of calves born from OSe- versus ISe-supplemented dams. Both Hsd17b7 and Akr1c4 are 
reported to affect the conversion of estrone to estradiol [76-77]. 
In the mouse, Hsd17b7 was first cloned from a mammary epithelial cell [78]. In the 
mouse embryos, Hsd17b7 is reported to affect the biosynthesis of cholesterol via the conversion 
of zymosterone to zymosterol [79] and in embryos developing in Hsd17b7 knockouts, fetal de 
novo cholesterol biosynthesis is affected resulting in embryonic death around day 10.5 [79].  
This steroidogenic mediator is also expressed in the corpus luteum (CL) of a range of 
mammalian species, suggesting a role in estradiol biosynthesis within that transient endocrine 
gland [77].  Distribution of Hsd17b7 among organs appears wide, with abundant expression 
noted in the adrenal glands, liver, lung and thymus [78] with lower expression observed in the 
mouse testis [80].  
Akr1c4 is reported to affect the conversion of androstanediol to dihydrotestosterone 
(DHT) in the prostate [60], the hepatic formation of the 3α,5β-THS (tetrahydrosteroid) of 
testosterone [81] and aid in the conversion of androst-4-en-3,17-dione to testosterone [76].  It is 
known as a general ketosteroid that can “interconvert active androgens and estrogens with their 
inactive metabolites” [82-83]. Akr1c4 is also referred to as PGF synthase (prostaglandin-F 
synthase) and it catalyzes the reduction of PGD2 to 9α-,11β-PGF2 [84-85].  Prostaglandins have 
been shown to increase cholesterol side-chain cleavage activity in the mitochondria of bovine 
adrenal cortex [86]. This activity change may imply that the conversion of cholesterol to 
pregnenolone, the steroid precursor, could also be increased by prostaglandins. 9α-,11β-PGF2 is 
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an intermediate metabolite in arachidonic acid metabolism; arachidonic acid is necessary for 
StAR gene transcription, as observed in mouse MA-10 Leydig cells [87].   
Expression of mRNA encoding Hsd17b4 was also differentially affected by 
supplementation regimen.  In the testis of calves born to MIX-supplemented dams, levels of 
mRNA for Hsd17b4 were lower than in the testis of calves born to both OSe- and ISe-
supplemented dams.  No differences were detected in the expression of mRNA for Hsd17b4 
among testis of calves born to OSe- and ISe-supplemented dams.  Hsd17b4 is an oxidative 
enzyme that has been shown to have effects on fatty acid and estradiol oxidation [88]. This 
enzyme promotes estrone production and may also oxidize ∆5-androstenediol to DHEA 
(dehydroepiandrosterone) [88]. Hsd17b4 has also been observed to inactivate 17β-estradiol and 
5-androstone-3β,17β-diol in the leydig and sertoli cells of the porcine testis [82, 89]. It has also 
been shown that in the liver of boars with differing levels of androstenone, those animals with 
higher androstenone had an upregulation of Hsd17b4 expression when compared to those that 
had lower levels [90].  
Levels of mRNA for Sult1e1 were higher in the testis of calves born from MIX-
supplemented dams than in the testis of calves born from OSe- or ISe-supplemented dams. 
Again, no difference was detected in the expression of mRNA for Sult1e1 among testis of calves 
born to OSe- versus ISe-supplemented dams.  Estrogen sulfotransferase is involved in the 
catabolism of estradiol, catalyzing sulfate conjugation of a range of hormones, but with a “high 
affinity for estrogens” [91]. Expression of this enzyme will therefore affect any estrogenic role 
within the testis, with high levels of expression reported in the epididymis of cattle, humans and 
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hamsters [91]. In mice, Sult1e1 was found specifically in the Leydig cells of the testis; it was 
later found in the liver of humans and rodents [92]. The importance of this gene expression was 
observed in knockout animals: the lack of Sult1e1 resulted in only 30-50% of normal 
testosterone production, abnormal testis structures, and lowered sperm motility of adult male 
mice [92].  
The supplementation regimen also affected mRNA expression encoding a cytochrome 
p450 enzyme.  Levels of mRNA for Cyp2s1 were higher in the testis of calves born from OSe-
supplemented dams than in the testis of calves born from MIX-supplemented dams.  Cytochrome 
p450 enzymes are involved in the oxidation of organic substances [93], including mediating the 
conversion of testosterone to estradiol [94].  Specifically, Cyp2s1 is also involved in 
coordinating the conversion of testosterone to 19-hydroxytestosterone [76]. This enzyme is 
responsible for the metabolism of retinoic acid as well, which is an important nutrient for 
spermatogonial differentiation and male meiosis [95-97].  
Several genes involved in spermatogenesis have also been identified to play a role in 
testicular steroidogenesis. Expression of Npr1 was significantly increased in calves born to OSe 
dams when compared to both MIX- and ISe-calves. Npr1 has been reported to affect the NPRA-
dependent cGMP steroidogenic pathway, an alternate to the common gonadotropin regulated 
cAMP pathway [98]. In Npr1 knockout mice, serum testosterone levels were 64% less than their 
wild type counterparts [98]. Levels of mRNA were similar between OSe and ISe-supplemented 
animals, while the Tlr3 expression in MIX-supplemented calves was lower.  Tlr3 is responsible 
for triggering the testicular innate immune response, which results in a decrease in testosterone 
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levels [99]. The influx of inflammatory cytokine production suppresses Leydig cell 
steroidogenesis [99]; the inflammation inhibits gonadotropin secretion [100] and decreases the 
immunosuppressive levels of testosterone [99]. Levels of mRNA for Cdk5r1 did not differ 
between OSe and ISe calves, and MIX calves were higher than OSe but not ISe animals.  
Expression of Cdk5r1 has been reported to increase StAR protein accumulation; alterations in 
Cdk5r1 protein expression have also affected testosterone production by Leydig cells in mice 
[101]. Although these genes play a more significant role in spermatogenesis in the male animal, 
their functions in testicular steroidogenesis should not be overlooked.  
Although the exact mechanism and involvement of all of these genes are still under 
scrutiny, it has been shown that all 8 mentioned have played some part in steroid synthesis. The 
steroidogenic capacity of the male, particularly the testis, is very important to fertility. Changes 
in gene expression from different Se treatments may impact the adult male, especially in terms of 
testosterone and sperm production. Decreased testosterone, may lead to lower libido, which 
could be directly related to fertility (number of cows that a bull will impregnate). It is not clear 
how these differences will alter the adult bull’s fertility, but the variation in neonatal testis points 
towards a treatment effect that needs further elucidation. Further research will need to focus on 
the DEG in the testis and follow these animals throughout adulthood; to observe the effects of Se 
source on male testosterone levels, libido, sperm production, and overall fertility. 
 
 
 
 49 
 
 
Figure 2.5. Steroidogenesis in the testis. A) Production of testosterone B) Conversion of 
testosterone to estradiol 
A) 
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Figure 2.6. Androgen/Estrogen biosynthesis pathway (adapted from Ingenuity pathway 
analysis). Differentially expressed genes involved in steroidogenesis are indicated. 
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SUMMARY 
 
 The effect of selenium form is known regarding tissue assimilation, whole blood levels, 
and hepatic gene expression profiles. It has now been shown that gestational form of selenium 
affects steroidogenic gene expression in the neonatal calf testis. Further research will need to be 
performed to determine the effects the mRNA expression differences may have on protein levels 
and physiological changes, in addition to semen characteristics, hormone concentrations and 
libido in adult bulls. Overall, 1112 genes were observed to be altered by Se treatment, however 
after pathway analysis, 8 were shown to be involved in steroidogenesis and/or steroid receptor 
binding. OSe forms increased amounts of Akrc14, Hsd17b4, Tlr3, Npr1 and Hsd71b7. Animals 
with the highest amounts of Sult1e1, Cyp2s1 and Cdk5r1 expression were seen in MIX 
treatments. In most expressions, with the exception of HSd71b7 and Npr1 Ise was similar to OSe 
levels. Differences, with ISe standardized as 1.00, are shown in Table 2.4. 
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Table 2.4. Gene expression comparisons with ISe standardized as 1.000 
Gene Symbol OSe1 MIX1 ISe2 
Akrc14 1.009  0.812 1.000 
Hsd17b4 1.002 0.980 1.000 
Tlr3 1.024 0.996 1.000 
Sult1e1 1.00 1.046 1.000 
Npr1 1.026 1.001 1.000 
Cyp2s1 0.988 1.022 1.000 
Cdk5r1 0.986 1.025 1.000 
Hsd17b7 1.042 0.957 1.000 
1Values calculated by OSe/ISe or MIX/ISe (from table 2.2) 
2ISe standardized as “1.000” for easy comparison 
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APPENDIX 
FOLLICULOGENESIS 
Overview 
 
Folliculogenesis is the development of follicles in the ovary and the subsequent 
recruitment, selection, and refinement of the dominant follicle that will ovulate [102].  Each 
follicle, regardless of dominance, goes through various stages of growth, regression and 
inactivity [103].  In cattle, these periods of follicular growth occur in 2-3 waves; changes in 
follicle stimulating hormone (FSH) and luteinzing hormone (LH) levels influence these waves 
[103]. It is not until the second or third wave that a dominant follicle emerges in the correct 
period of luteal regression and may develop into one that has the capacity to ovulate, known as a 
Graafian follicle. The beginning of this process is characterized by a surge of FSH; as the cycle 
proceeds, the FSH amount decreases (associated with selection) and the dominant follicle 
becomes more receptive to LH. As the dominant follicle matures, the number of LH receptors in 
the granulose cells increases [103]. High levels of FSH have been observed on the actual day of 
estrus, which correlates to an LH peak [104]. This decrease in FSH is vital in establishing the 
growth of the dominant follicle in each wave [105].  Once the dominant follicle has been 
recruited and selected, it continues to grow until its ultimate fate of ovulation or atresia.  
The Estrous Cycle 
 
 The day of estrus, or standing heat, is often termed Day 0 and is characterized by a high 
level of estradiol. Days 2-5 involve luteinization, when the follicle’s cells become luteal cells and 
initiate the production of progesterone. Days 5-16 are defined by luteal growth; this period is 
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known as diestrus, and characterized by high levels of progesterone preventing LH release. 
Follicular growth begins between days 16 and 18, with estradiol and prostaglandin levels 
increasing as the corpus luteum (CL) regresses. The dominant follicle is selected and recruited 
during days 18/19 where low progesterone levels can be observed, resulting from an inactive CL. 
Day 19 or 20 of the cycle is characterized by another standing heat and high levels of estradiol. 
Following ovulation, the cycle restarts. If the dominant follicle develops during a time when the 
CL is functional, it will become atretic and turn over. A new wave begins and continues through 
the cycle; cattle have 2-3 wave cycles [106].  
Progression of the Follicle 
 
 The entire process of follicular development, from primordial stages to ovulation, has 
been shown to take approximately 180 days in cattle [107]. The early steps of follicular 
formation begin during gastrulation and embryo development. Primordial germ cells (PGCs) 
originate from the embryonic yolk sac and move to the genital ridge, or the undifferentiated 
gonad [108] [109]. As the PGCs undergo mitotic divisions, they become enclosed by somatic 
cells and are referred to as oogonia [108, 110]. These oogonia are arrested in prosphase I of 
meiosis I until the LH surge triggers the completion of meiosis I and the initiation of meiosis II 
[111]. A single layer of flattened, inactive granulosa cells marks the transition of oogonia to 
primordial follicles [108, 111]. This stage, with the previous two mentioned, are classified as 
gonadotropin independent, implying that they are fully capable of growth and development in the 
absence of LH and FSH. Follicular growth is independent of gonadotropin levels up until about 4 
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mm in cattle. Further growth requires FSH and later (when the follicle reaches a size greater than 
9 mm), LH activity.  
 The population of primordial follicles serves as the “pool” from which all ovulated 
follicles originate in the cow’s reproductive life [112]. Primary follicles, the next stage of 
follicular development, can be identified by a single layer of cuboidal granulosa cells and the 
recruitment of theca cells from the stromal layers [108]. In this stage of development, the zona 
pellucida begins to form and the cells become slightly more responsive to gonadotropins [107].  
 The primary follicles undergo further mitotic divisions and become preantral, or 
secondary, follicles. Multiple layers of cuboidal granulosa cells and identifiable theca cells 
(separate from the basement membrane) are recognizable features at this stage [107]. Tertiary, or 
antral follicles, are defined by the presence of a fluid-filled cavity called an antrum [107] [111]. 
The continued growth of these follicles requires an increase in gonadotropin levels (FSH and 
LH).  The granulosa cells contain FSH-receptor mRNA while the theca interna contains LH-
receptor mRNA, although the granulosa cells acquire these LH receptors when approaching 
ovulation. It is this acquisition that can be used to determine the ovulatory capability of an 
individual follicle [113].  
 During follicular growth, until the follicle diameter is between 2 and 3 mm, the zona 
pellucida begins to form, cortical granules begin to form in the oocyte cytoplasm (which will 
later be important in fertilization), and RNA synthesis begins [113].  
 The formation of the antrum divides the granulosa cells into two separate groups: 
cumulus cells which interact with the oocyte and mural cells that line the follicle wall [112].  
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Graafian follicles are well-developed antral follicles termed periovulatory follicles after the 
“preovulatory gonadotropin surge” occurs [112]. The LH surge triggers the follicle to resume 
and complete meiosis I. The oocyte continues to grow and undergoes meiosis II, where it is 
arrested until fertilization.  
Recruitment, Selection, and Dominance 
 
 As luteal regression occurs, the large dominant follicle that continues to grow will likely 
be selected for differentiation and eventual ovulation. Recruitment is defined as the growth of a 
group of antral follicles in the presence of gonadotropins, stimulated by a slight increase in FSH 
[107] [114-115]. When one follicle undergoes even more rapid growth, and becomes truly 
dominant, the stage is called selection. After selection, this dominant follicle “avoids atresia, 
inhibits the recruitment of a new cohort of follicles, and acquires competence to achieve 
ovulation” [107]. During selection, there is an increase in serum estradiol concentrations [113]. 
The expression of estradiol helps to promote steroid synthesis; the action of FSH on aromatase is 
increased, granulosa cells are induced to express FSH/LH receptors, and gap junction formation 
is encouraged [113]. Once follicles achieve a diameter of approximately 5 mm, they begin to 
suppress FSH action, thereby reducing the FSH activity for the entire ovary [116-118]. The 
ability of cattle to be superovulated, which results in multiple dominant follicles in a particular 
cycle, exhibits the potential of FSH to be maintained and prevent selection in the normal sense 
from occurring [119]. This addition of FSH in superovulation protocols allows the smaller 
follicles to grow and become dominant. 
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As the follicle begins to deviate, the observed diameter increase is associated with an 
increase in estradiol concentrations, detected in both the systemic blood and the follicular fluid 
[116, 120]. The rise of estradiol continues to decrease the activity of FSH, allowing the dominant 
follicle to grow and the smaller follicles to become atretic [116]. There is a slight increase in LH 
circulation at the start of this follicle deviation; it does not appear to be necessary for the 
initiation of deviation but mainly for the continued growth of the dominant follicle [121]. The 
elevation of LH concentrations also contributes to the increasing levels of estradiol, IGF-1, and 
androstenedione in follicular fluid [121].  
Atretic follicles, particularly dominant follicles that turn over, are extremely sensitive to 
LH changes; small alterations in LH pulse frequency may result in the loss of LH receptors and 
cause “atresia (low LH pulse frequency) or luteinization (high LH pulse frequency)” [122]. 
Selection and dominance appear to be regulated by the increase in theca cell capacity to 
produce androgens and the increased ability of granulosa cells to aromatize those androgens into 
estrogens [114]. The dominant follicle is one that has competed with the others, acquired LH 
receptors, suppressed FSH activity to a minimum, and continues to grow [119]. 
Theca and Granulosa Cells 
 
Folliculogenesis is a process that is very sensitive to varying gonadotropin and hormone 
levels.  The mRNA expression of estrogen receptors has been shown to increase in the theca 
cells as follicular development progresses [123].  In examined cells, progesterone receptor 
mRNA also increased in the theca interna [123]. Estradiol aids in the  vascularization of the 
follicle and helps improve the intake of other gonadotropins and nutrients [124-125].   
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The follicle contains several structures with the most important to this study, and 
therefore to this review, being the theca cells and the granulosa cells. Theca cells are necessary 
for the conversion of progesterone into androgens [103]. Research shows that androgens 
produced by the theca cells are then taken up by the granulosa cells and further converted [123]. 
Theca cells are able to produce androgens when exposed to LH [126]. This feedback loop 
involves the theca cells producing androgens and the granulosa cells aromatizing these into 
estrogens which are, in turn, important in the stimulation of theca cell action [123].  The further 
progression of folliculogenesis is associated with a slight LH surge, which contributes to the 
increase in capability of the theca cells to produce androgens and granulosa cells to convert the 
androgens into estradiol [52, 114]. Granulosa cells convert the androgens produced by the theca 
cells into estrogen; these cells are stimulated by FSH and aromatase.  
Hormone Levels in Follicular Waves  
 
Luteinizing hormone and follicle stimulating hormone are important hormones in the 
regulation of follicular waves and dominant follicle growth.  
 Follicle stimulating hormone is necessary for the growth of follicles, particularly the 
transition of secondary follicles to tertiary ones; it also stimulates the estradiol production in 
Graafian follicles [106]. Increases in FSH result in the emergence of small (3-5 mm) follicles as 
a group to begin the follicular wave [127]. If a dominant follicle turns over, or if the LH levels 
are negated by the CL’s production of progesterone, a subsequent increase in FSH occurs to 
usher in a new wave and a new dominant follicle [127]. Those follicles that can grow and secrete 
estradiol with this FSH rise are considered “successful.” The decline of FSH is also extremely 
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important in the selection of a dominant follicle, research shows that the continuation of high 
FSH levels results in a dominant follicle not being selected [127]. Under the influence of FSH 
the androgens produced from the theca cells and transported into the granulosa cells are 
aromatized to estrogens [52, 128-129]. 
An LH surge is responsible for the resumption of meiosis by the oocyte and the last stage 
of follicular growth. Prior to the surge, LH levels are at a basal level and increase significantly as 
the animal approaches ovulation. After ovulation, pulses of LH are frequent, albeit with small 
amplitudes. As folliculogenesis progresses, the corpus luteum (CL) forms and progesterone is 
produced, resulting in less frequent LH pulses [130].  
The accumulation and increase in progesterone concentration results in a decrease in LH 
pulses; there is a negative feedback interaction of progesterone on LH. When progesterone 
increases later in the estrous cycle (~day 10 or so), the pulses of LH begin to diminish in 
frequency and increase in amplitude; and vice versa, as the progesterone decreases, the LH 
pulses increase [130]. During the follicular phase, which occurs late in the cycle when the next 
ovulation event is approaching, progesterone is low and GnRH/LH pulses increased. These 
increases allow the follicle to achieve the last stages of maturation and growth before ovulation. 
The follicle secretes estradiol triggering the hypothalamus to release more GnRH, whose release 
in turn stimulates the anterior pituitary to release the surge of LH.  
Summary 
 
The process of folliculogenesis is regulated by multiple hormones and growth factors. It 
is a complex cycle that must occur correctly or reproductive efficiency will be reduced. The 
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common patter or recruitment, selection, and dominance does not leave room for error; any slight 
changes may significantly impact the reproductive capacity and profitability of the animal.  
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